September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
ACS Journal Cancer Editor-in-Chief, Suresh S. Ramalingam, is sharing the primary results of the phase 3 LAURA trial at ASCO
May 24, 2024, 14:15

ACS Journal Cancer Editor-in-Chief, Suresh S. Ramalingam, is sharing the primary results of the phase 3 LAURA trial at ASCO

ACS Journal Cancer shared the following on X:

Our Editor-in-Chief, Suresh S. Ramalingam, is sharing the primary results of the phase 3 LAURA trial at this year’s ASCO Plenary Session! ICYMI: Dr. Ramalingam and Ticiana Batista recently authored an editorial on the 20th anniversary of EGFR.

Source: ACS Journal Cancer/X
>